CHE vs REG · P/E 24, rev $2.43B vs P/E 34, $12.93B cap
Chemed Corp (CHE) versus Regency Centers Corporation (REG) — a side-by-side from cached financials, not a winner call.
Chemed Corp (CHE) is a medical care facilities company listed on NYSE.
Regency Centers Corporation (REG) is a reit - retail company listed on US.
Latest reported CHE revenue for 2024-12-31 was $2.43B. Net income was $302.0M. Revenue was up 7.4% from 2023-12-31 to 2024-12-31. CHE currently screens at market cap $5.79B and trailing P/E 23.8.
REG does not have a complete income-statement cache yet.
CHE currently screens at market cap $5.79B and trailing P/E 23.8. REG currently screens at market cap $12.93B and trailing P/E 33.5.
Not investment advice. Open the CHE and REG stock pages for the full models.
Not investment advice.